Home Newsfeeds Baird Maintains Outperform on TransUnion, Lowers Price Target to $87

Baird Maintains Outperform on TransUnion, Lowers Price Target to $87

Baird analyst Jeffrey Meuler maintains TransUnion (NYSE:TRU) with a Outperform and lowers the price target from $112 to $87.

byBenzinga Newsdesk

July 27, 2022

1 minute read

Baird analyst Jeffrey Meuler maintains TransUnion (NYSE:TRU) with a Outperform and lowers the price target from $112 to $87.

DA Davidson Maintains Buy on Beauty Health, Raises Price Target to $35

By Benzinga Newsdesk

March 1, 5:53 AM

DA Davidson analyst Linda Bolton Weiser maintains Beauty Health (NASDAQ:SKIN) with a Buy and raises the price target from $32 to $35.

SKIN

Eldorado Gold Q2 EPS $0.08 Misses $0.13 Estimate

By Benzinga Newsdesk

July 28, 5:08 PM

Eldorado Gold (NYSE:EGO) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.13 by 38.46 percent. This is a 50 percent decrease over earnings of $0.16 per share from the same

EGO

Shavo Odadjian’s Cannabis Brand 22Red Unleashes 4 Premium Strains On Arizona

By Javier Hasse

June 16, 1:33 PM

With the heat of summer settling over Arizona, cannabis connoisseurs have a new reason to celebrate. Renowned brand, 22Red, has launched four exciting new strains of their superior indoor-grown flower, promising to add a refreshing and elevating twist to the coming months.

CURLF

Development Of DMT Transdermal Patch With Eye Disease Treatment In Mind

By Lara Goldstein

February 22, 2:43 PM

Specialty R&D psychedelics company PharmaDrug Inc. (OTCQB: LMLLF) has inked a research collaboration agreement with PharmaTher Holdings Ltd. (OTCMKTS: PHRRF) to evaluate the delivery of DMT through PharmaTher's microneedle patch technology.

LMLLF

Baird Maintains Outperform on TransUnion, Lowers Price Target to $87

Related Posts

DA Davidson Maintains Buy on Beauty Health, Raises Price Target to $35

Eldorado Gold Q2 EPS $0.08 Misses $0.13 Estimate

Shavo Odadjian’s Cannabis Brand 22Red Unleashes 4 Premium Strains On Arizona

Development Of DMT Transdermal Patch With Eye Disease Treatment In Mind